Wednesday, October 06, 2021 3:23:06 PM
In my head I had that korea would recruit 20 pts, but I cannot find that info anymore. Do you have any source for the 50 pts ?
On July 22nd, South Korea announced a phase I lenzilumab safety trial of 20 patients. It wasn't part of the ACTIV-5 trial.
https://ih.advfn.com/stock-market/NASDAQ/humanigen-HGEN/stock-news/85648204/humanigen-s-partner-in-south-korea-receives-minis
On August 30th, it was announced that 50 patients in the ACTIV-5 would be enrolled in South Korea.
#lenzilumab BET-B study has been approved in South Korea just now.
— gbe_estory (@EstoryGbe) August 30, 2021
50 out of 400 patients will be selected in Korea.$hgen $telcon $kpmtech #remdesivir vs #lenzilumab pic.twitter.com/HMVZpUvjAL
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
